PCTY Paylocity | $177.19 -0.3% | 10/23/2026 | | Boost Price Target | $180.00 ➝ $200.00 | Buy | 00.00% | View details for Guggenheim rating of Paylocity (NASDAQ:PCTY) on 10/23/2026 |
APPF AppFolio | $210.62 -3.1% | 10/23/2026 | | Boost Price Target | $232.00 ➝ $239.00 | Buy | 00.00% | View details for Guggenheim rating of AppFolio (NASDAQ:APPF) on 10/23/2026 |
NOW ServiceNow | $159.30 +1.5% | 10/23/2026 | | Reiterated Rating | $125.00 ➝ $175.00 | Buy | 00.00% | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 10/23/2026 |
ADP Automatic Data Processing | $304.16 -1.2% | 10/23/2026 | | Boost Price Target | $300.00 ➝ $340.00 | Buy | 00.00% | View details for Guggenheim rating of Automatic Data Processing (NASDAQ:ADP) on 10/23/2026 |
ARGX argenex | $873.71 -0.2% | 10/23/2026 | | Lower Price Target | $1,185.00 ➝ $1,120.00 | Buy | 00.00% | View details for Guggenheim rating of argenex (NASDAQ:ARGX) on 10/23/2026 |
AVTX Avalo Therapeutics | $6.93 -7.0% | 10/23/2026 | | Reiterated Rating | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Avalo Therapeutics (NASDAQ:AVTX) on 10/23/2026 |
PAYC Paycom Software | $274.64 +0.7% | 10/23/2026 | | Boost Price Target | $225.00 ➝ $300.00 | Buy | 00.00% | View details for Guggenheim rating of Paycom Software (NYSE:PAYC) on 10/23/2026 |
SPOT Spotify Technology | $583.84 +0.0% | 10/23/2026 | | Boost Price Target | $575.00 ➝ $650.00 | Buy | 00.00% | View details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 10/23/2026 |
ELV Elevance Health | $440.05 -1.2% | 10/22/2026 | | Boost Price Target | $460.00 ➝ $485.00 | Buy | 00.00% | View details for Guggenheim rating of Elevance Health (NYSE:ELV) on 10/22/2026 |
META Meta Platforms | $642.62 -1.0% | 10/22/2026 | | Reiterated Rating | $850.00 | Buy | 00.00% | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 10/22/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
NKE NIKE | $37.32 -2.6% | 10/22/2026 | | Reiterated Rating | $50.00 | Buy | 00.00% | View details for Guggenheim rating of NIKE (NYSE:NKE) on 10/22/2026 |
MSFT Microsoft | $524.51 +0.7% | 10/21/2026 | | Reiterated Rating | $586.00 | Buy | 00.00% | View details for Guggenheim rating of Microsoft (NASDAQ:MSFT) on 10/21/2026 |
NOC Northrop Grumman | $551.38 -0.2% | 10/21/2026 | | Boost Price Target | $612.00 ➝ $640.00 | Buy | 00.00% | View details for Guggenheim rating of Northrop Grumman (NYSE:NOC) on 10/21/2026 |
GE GE Aerospace | $285.76 -2.7% | 10/21/2026 | | Set Price Target | $380.00 | | 00.00% | View details for Guggenheim rating of GE Aerospace (NYSE:GE) on 10/21/2026 |
FUN Six Flags Entertainment | $6.78 -6.3% | 10/21/2026 | | Lower Price Target | $28.00 ➝ $17.00 | Buy | 00.00% | View details for Guggenheim rating of Six Flags Entertainment (NYSE:FUN) on 10/21/2026 |
KR Kroger | $66.88 -1.5% | 10/21/2026 | | Reiterated Rating | $66.00 ➝ $68.00 | Buy | 00.00% | View details for Guggenheim rating of Kroger (NYSE:KR) on 10/21/2026 |
KZIA Novogen | $7.81 -3.2% | 10/21/2026 | | Initiated Coverage | $35.00 | Buy | 00.00% | View details for Guggenheim rating of Novogen (NASDAQ:KZIA) on 10/21/2026 |
NFLX Netflix | $65.85 -1.8% | 10/21/2026 | | Lower Price Target | $80.00 ➝ $78.00 | Buy | 00.00% | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/21/2026 |
RAPP Rapport Therapeutics | $25.93 -2.3% | 10/20/2026 | | Boost Price Target | $65.00 ➝ $70.00 | Buy | 00.00% | View details for Guggenheim rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/20/2026 |
TKO TKO Group | $172.86 -2.7% | 10/20/2026 | | Lower Price Target | $235.00 ➝ $228.00 | Buy | 00.00% | View details for Guggenheim rating of TKO Group (NYSE:TKO) on 10/20/2026 |
ABVX Abivax | $88.01 -2.5% | 10/20/2026 | | Reiterated Rating | $175.00 | Buy | 00.00% | View details for Guggenheim rating of Abivax (NASDAQ:ABVX) on 10/20/2026 |
EQIX Equinix | $955.03 +0.3% | 10/20/2026 | | Reiterated Rating | $1,235.00 | Buy | 00.00% | View details for Guggenheim rating of Equinix (NASDAQ:EQIX) on 10/20/2026 |
TEAM Atlassian | $227.61 +2.0% | 10/19/2026 | | Boost Price Target | $165.00 ➝ $280.00 | Buy | 00.00% | View details for Guggenheim rating of Atlassian (NASDAQ:TEAM) on 10/19/2026 |
ARQT Arcutis Biotherapeutics | $31.20 -3.1% | 10/19/2026 | | Boost Price Target | $38.00 ➝ $44.00 | Buy | 00.00% | View details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 10/19/2026 |
EYPT Eyepoint Pharmaceuticals | $0.40 -5.5% | 10/19/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Eyepoint Pharmaceuticals (NASDAQ:EYPT) on 10/19/2026 |
THC Tenet Healthcare | $268.13 -0.9% | 10/16/2026 | | Boost Price Target | $283.00 ➝ $307.00 | Buy | 00.00% | View details for Guggenheim rating of Tenet Healthcare (NYSE:THC) on 10/16/2026 |
UBER Uber Technologies | $66.53 -3.7% | 10/16/2026 | | Reiterated Rating | $125.00 | Buy | 00.00% | View details for Guggenheim rating of Uber Technologies (NYSE:UBER) on 10/16/2026 |
TMO Thermo Fisher Scientific | $673.97 -0.4% | 10/15/2026 | | Initiated Coverage | | Buy | 00.00% | View details for Guggenheim rating of Thermo Fisher Scientific (NYSE:TMO) on 10/15/2026 |
TMO Thermo Fisher Scientific | $673.97 -0.4% | 10/15/2026 | | Reiterated Rating | $740.00 | Buy | 00.00% | View details for Guggenheim rating of Thermo Fisher Scientific (NYSE:TMO) on 10/15/2026 |
SHAK Shake Shack | $65.11 -4.1% | 10/15/2026 | | Reiterated Rating | $90.00 | Buy | 00.00% | View details for Guggenheim rating of Shake Shack (NYSE:SHAK) on 10/15/2026 |
DASH DoorDash | $179.38 -3.5% | 10/14/2026 | | Reiterated Rating | $255.00 | Buy | 00.00% | View details for Guggenheim rating of DoorDash (NASDAQ:DASH) on 10/14/2026 |
META Meta Platforms | $642.62 -1.0% | 10/14/2026 | | Boost Price Target | $700.00 ➝ $850.00 | Buy | 00.00% | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 10/14/2026 |
SPHR Sphere Entertainment | $109.07 -2.3% | 10/14/2026 | | Lower Price Target | $208.00 ➝ $180.00 | Buy | 00.00% | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 10/14/2026 |
AMGN Amgen | $439.26 -1.8% | 10/13/2026 | | Lower Price Target | $388.00 ➝ $378.00 | Neutral | 00.00% | View details for Guggenheim rating of Amgen (NASDAQ:AMGN) on 10/13/2026 |
PFE Pfizer | $30.04 -1.3% | 10/13/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 10/13/2026 |
GEV GE Vernova | $814.37 -1.6% | 10/13/2026 | | Reiterated Rating | $1,450.00 | Buy | 00.00% | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 10/13/2026 |
P Everpure | $123.33 +1.8% | 10/12/2026 | | Boost Price Target | $150.00 ➝ $215.00 | Buy | 00.00% | View details for Guggenheim rating of Everpure (NYSE:P) on 10/12/2026 |
LBRX LB Pharmaceuticals | $38.73 -1.8% | 10/12/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of LB Pharmaceuticals (NASDAQ:LBRX) on 10/12/2026 |
ELV Elevance Health | $440.05 -1.2% | 10/12/2026 | | Boost Price Target | $455.00 ➝ $460.00 | Buy | 00.00% | View details for Guggenheim rating of Elevance Health (NYSE:ELV) on 10/12/2026 |
DCO Ducommun | $157.18 -1.8% | 10/9/2026 | | Initiated Coverage | $246.00 | Buy | 00.00% | View details for Guggenheim rating of Ducommun (NYSE:DCO) on 10/9/2026 |
Trump goes "all-in" on Grand Canyon energy breakthrough (Ad) A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years.
While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million.
One company controls the entire supply chain behind this discovery. See the ticker behind this Grand Canyon energy breakthrough now |
ABBV AbbVie | $285.66 +0.2% | 10/9/2026 | | Reiterated Rating | $288.00 | Buy | 00.00% | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 10/9/2026 |
DCO Ducommun | $157.18 -1.8% | 10/9/2026 | | Initiated Coverage | $246.00 | Buy | 00.00% | View details for Guggenheim rating of Ducommun (NYSE:DCO) on 10/9/2026 |
STUB STUB | $5.84 -4.3% | 10/9/2026 | | Lower Price Target | $11.00 ➝ $9.00 | Buy | 00.00% | View details for Guggenheim rating of STUB (NYSE:STUB) on 10/9/2026 |
ELVN Enliven Therapeutics | $41.52 -1.0% | 10/8/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Enliven Therapeutics (NASDAQ:ELVN) on 10/8/2026 |
LEU Centrus Energy | $102.38 -1.7% | 10/8/2026 | | Initiated Coverage | $167.00 | Buy | 00.00% | View details for Guggenheim rating of Centrus Energy (NYSE:LEU) on 10/8/2026 |
LEU Centrus Energy | $102.38 -1.7% | 10/8/2026 | | Initiated Coverage | $167.00 | Buy | 00.00% | View details for Guggenheim rating of Centrus Energy (NYSE:LEU) on 10/8/2026 |
AVBP ArriVent BioPharma | $21.00 +9.4% | 10/7/2026 | | Lower Price Target | $45.00 ➝ $18.00 | Buy | 00.00% | View details for Guggenheim rating of ArriVent BioPharma (NASDAQ:AVBP) on 10/7/2026 |
ZS Zscaler | $255.15 +7.3% | 10/7/2026 | | Boost Price Target | $214.00 ➝ $254.00 | Buy | 00.00% | View details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 10/7/2026 |
DKNG DraftKings | $20.91 -0.1% | 10/7/2026 | | Lower Price Target | $33.00 ➝ $30.00 | Buy | 00.00% | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 10/7/2026 |
DKNG DraftKings | $20.91 -0.1% | 10/7/2026 | | Lower Price Target | $33.00 ➝ $30.00 | Buy | 00.00% | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 10/7/2026 |
JNJ Johnson & Johnson | $264.13 -1.3% | 10/7/2026 | | Reiterated Rating | $287.00 | Buy | 00.00% | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 10/7/2026 |
LBRX LB Pharmaceuticals | $38.73 -1.8% | 10/6/2026 | | Initiated Coverage | $80.00 | Buy | 00.00% | View details for Guggenheim rating of LB Pharmaceuticals (NASDAQ:LBRX) on 10/6/2026 |
NBIX Neurocrine Biosciences | $142.70 -0.4% | 10/6/2026 | | Initiated Coverage | $207.00 | Buy | 00.00% | View details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 10/6/2026 |
OVID Ovid Therapeutics | $2.16 -8.9% | 10/6/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for Guggenheim rating of Ovid Therapeutics (NASDAQ:OVID) on 10/6/2026 |
RAPP Rapport Therapeutics | $25.93 -2.3% | 10/6/2026 | | Initiated Coverage | $65.00 | Buy | 00.00% | View details for Guggenheim rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/6/2026 |
XENE Xenon Pharmaceuticals | $35.34 -3.2% | 10/6/2026 | | Initiated Coverage | $73.00 | Buy | 00.00% | View details for Guggenheim rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 10/6/2026 |
YUM Yum! Brands | $149.75 -3.0% | 10/6/2026 | | Lower Price Target | $180.00 ➝ $155.00 | Buy | 00.00% | View details for Guggenheim rating of Yum! Brands (NYSE:YUM) on 10/6/2026 |
RAPP Rapport Therapeutics | $25.93 -2.3% | 10/5/2026 | | Initiated Coverage | $65.00 | Buy | 00.00% | View details for Guggenheim rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/5/2026 |
MPLT Maplight Therapeutics | $7.97 -3.4% | 10/5/2026 | | Initiated Coverage | | Neutral | 00.00% | View details for Guggenheim rating of Maplight Therapeutics (NASDAQ:MPLT) on 10/5/2026 |
LBRX LB Pharmaceuticals | $38.73 -1.8% | 10/5/2026 | | Initiated Coverage | $80.00 | Buy | 00.00% | View details for Guggenheim rating of LB Pharmaceuticals (NASDAQ:LBRX) on 10/5/2026 |
RAPP Rapport Therapeutics | $25.93 -2.3% | 10/5/2026 | | Initiated Coverage | $65.00 | Buy | 00.00% | View details for Guggenheim rating of Rapport Therapeutics (NASDAQ:RAPP) on 10/5/2026 |
GMAB Genmab A/S | $43.79 +9.5% | 10/5/2026 | | Boost Price Target | $45.00 ➝ $54.00 | Buy | 00.00% | View details for Guggenheim rating of Genmab A/S (NASDAQ:GMAB) on 10/5/2026 |
PCVX Vaxcyte | $60.43 -3.9% | 10/5/2026 | | Boost Price Target | $116.00 ➝ $125.00 | Buy | 00.00% | View details for Guggenheim rating of Vaxcyte (NASDAQ:PCVX) on 10/5/2026 |
MCD McDonald's | $248.49 -1.6% | 10/5/2026 | | Lower Price Target | $290.00 ➝ $250.00 | Neutral | 00.00% | View details for Guggenheim rating of McDonald’s (NYSE:MCD) on 10/5/2026 |
OVID Ovid Therapeutics | $2.16 -8.9% | 10/5/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for Guggenheim rating of Ovid Therapeutics (NASDAQ:OVID) on 10/5/2026 |
YSWY Yesway | $24.64 +0.6% | 10/5/2026 | | Reiterated Rating | $32.00 | Buy | 00.00% | View details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 10/5/2026 |
FHTX Foghorn Therapeutics | $2.00 -0.5% | 10/2/2026 | | Lower Price Target | $12.00 ➝ $5.00 | Buy | 00.00% | View details for Guggenheim rating of Foghorn Therapeutics (NASDAQ:FHTX) on 10/2/2026 |
SGMT Sagimet Biosciences | $9.58 -3.7% | 10/2/2026 | | Boost Price Target | $25.00 ➝ $26.00 | Buy | 00.00% | View details for Guggenheim rating of Sagimet Biosciences (NASDAQ:SGMT) on 10/2/2026 |
MBX MBX Biosciences | $48.50 -3.9% | 10/2/2026 | | Boost Price Target | $88.00 ➝ $150.00 | Buy | 00.00% | View details for Guggenheim rating of MBX Biosciences (NASDAQ:MBX) on 10/2/2026 |
NKE NIKE | $37.32 -2.6% | 10/2/2026 | | Reiterated Rating | $60.00 ➝ $50.00 | Buy | 00.00% | View details for Guggenheim rating of NIKE (NYSE:NKE) on 10/2/2026 |
FHTX Foghorn Therapeutics | $2.00 -0.5% | 10/2/2026 | | Lower Price Target | $12.00 ➝ $5.00 | Buy | 00.00% | View details for Guggenheim rating of Foghorn Therapeutics (NASDAQ:FHTX) on 10/2/2026 |
ACN Accenture | $249.42 -3.6% | 10/2/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Accenture (NYSE:ACN) on 10/2/2026 |
WAT Waters | $453.42 -0.5% | 10/1/2026 | | Boost Price Target | $440.00 ➝ $490.00 | Buy | 00.00% | View details for Guggenheim rating of Waters (NYSE:WAT) on 10/1/2026 |
TWST Twist Bioscience | $139.92 +3.3% | 10/1/2026 | | Boost Price Target | $107.00 ➝ $212.00 | Buy | 00.00% | View details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 10/1/2026 |
TEM Tempus AI | $67.61 +6.0% | 10/1/2026 | | Boost Price Target | $65.00 ➝ $92.00 | Buy | 00.00% | View details for Guggenheim rating of Tempus AI (NASDAQ:TEM) on 10/1/2026 |
NTRA Natera | $403.95 +0.6% | 10/1/2026 | | Boost Price Target | $360.00 ➝ $475.00 | Buy | 00.00% | View details for Guggenheim rating of Natera (NASDAQ:NTRA) on 10/1/2026 |
ILMN Illumina | $269.42 +0.0% | 10/1/2026 | | Boost Price Target | $226.00 ➝ $305.00 | Buy | 00.00% | View details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 10/1/2026 |
GH Guardant Health | $169.08 +3.8% | 10/1/2026 | | Boost Price Target | $190.00 ➝ $200.00 | Buy | 00.00% | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 10/1/2026 |
DHR Danaher | $230.36 +0.3% | 10/1/2026 | | Boost Price Target | $200.00 ➝ $250.00 | Buy | 00.00% | View details for Guggenheim rating of Danaher (NYSE:DHR) on 10/1/2026 |
CYRX CryoPort | $17.98 +0.8% | 10/1/2026 | | Boost Price Target | $16.00 ➝ $19.00 | Buy | 00.00% | View details for Guggenheim rating of CryoPort (NASDAQ:CYRX) on 10/1/2026 |
BRKR Bruker | $57.59 +0.5% | 10/1/2026 | | Boost Price Target | $70.00 ➝ $72.00 | Buy | 00.00% | View details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 10/1/2026 |
BLLN Billiontoone | $107.77 +2.0% | 10/1/2026 | | Boost Price Target | $125.00 ➝ $128.00 | Buy | 00.00% | View details for Guggenheim rating of Billiontoone (NASDAQ:BLLN) on 10/1/2026 |
ADPT Adaptive Biotechnologies | $25.51 +4.5% | 10/1/2026 | | Boost Price Target | $25.00 ➝ $32.00 | Buy | 00.00% | View details for Guggenheim rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 10/1/2026 |
NFLX Netflix | $65.85 -1.8% | 10/1/2026 | | Reiterated Rating | $75.00 ➝ $80.00 | Buy | 00.00% | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/1/2026 |
GRAL GRAIL | $132.55 +4.3% | 10/1/2026 | | Boost Price Target | $75.00 ➝ $155.00 | Buy | 00.00% | View details for Guggenheim rating of GRAIL (NASDAQ:GRAL) on 10/1/2026 |
WGS GeneDx | $56.15 -16.4% | 10/1/2026 | | Boost Price Target | $74.00 ➝ $83.00 | Buy | 00.00% | View details for Guggenheim rating of GeneDx (NASDAQ:WGS) on 10/1/2026 |
DKS DICK'S Sporting Goods | $144.62 -2.8% | 9/30/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of DICK’S Sporting Goods (NYSE:DKS) on 9/30/2026 |
NEOG Neogen | $12.19 +1.8% | 9/30/2026 | | Reiterated Rating | $12.00 ➝ $14.00 | Buy | 00.00% | View details for Guggenheim rating of Neogen (NASDAQ:NEOG) on 9/30/2026 |
ZBIO Zenas BioPharma | $26.87 -4.8% | 9/30/2026 | | Reiterated Rating | $55.00 | Buy | 00.00% | View details for Guggenheim rating of Zenas BioPharma (NASDAQ:ZBIO) on 9/30/2026 |
BWXT BWX Technologies | $127.27 0.0% | 9/30/2026 | | Reiterated Rating | $192.00 | Buy | 00.00% | View details for Guggenheim rating of BWX Technologies (NYSE:BWXT) on 9/30/2026 |
Why tech stocks are dead (Ad) AI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the big tech names pouring billions into data centers.
Walmart's $24 million satellite network, AMR's Sabre system, and Capital One's 36,114 pricing tests all prove the same thing: compute has always been business's biggest moat, and it's about to get cheaper than ever.
Porter Stansberry says one overlooked, government-protected sector is positioned to absorb this near-free compute boom and could become the next Magnificent 7. Watch Porter Stansberry's broadcast to see which sector could lead next |
MDB MongoDB | $371.09 +2.4% | 9/29/2026 | | Reiterated Rating | $560.00 | Buy | 00.00% | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 9/29/2026 |
AIR AAR | $95.30 -1.4% | 9/29/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of AAR (NYSE:AIR) on 9/29/2026 |
WMG Warner Music Group | $30.86 -2.6% | 9/29/2026 | | Reiterated Rating | $36.00 | Buy | 00.00% | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 9/29/2026 |
COST Costco Wholesale | $1,003.32 -1.5% | 9/28/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Costco Wholesale (NASDAQ:COST) on 9/28/2026 |
DIS Walt Disney | $112.61 -0.5% | 9/28/2026 | | Reiterated Rating | $120.00 | Buy | 00.00% | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 9/28/2026 |
FSLR First Solar | $171.99 +0.4% | 9/28/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 9/28/2026 |
ABSI Absci | $9.18 -2.0% | 9/28/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Absci (NASDAQ:ABSI) on 9/28/2026 |
KRSA Cyclerion Therapeutics | $31.31 -6.3% | 9/28/2026 | | Initiated Coverage | $70.00 | Buy | 00.00% | View details for Guggenheim rating of Cyclerion Therapeutics (NASDAQ:KRSA) on 9/28/2026 |
ZS Zscaler | $255.15 +7.3% | 9/25/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 9/25/2026 |
AKAM Akamai Technologies | $93.53 +2.6% | 9/25/2026 | | Boost Price Target | $190.00 ➝ $225.00 | Buy | 00.00% | View details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 9/25/2026 |